Buprenorphine — 2MG, Tablet, bottle of 30 tablets

Buprenorphine — 2MG, Tablet, bottle of 30 tablets

Buprenorphine is a tablet for sublingual use. Buprenorphine sublingual tablet is indicated for the treatment of opioid dependence and is preferred for induction. Buprenorphine sublingual tablet should be used as part of a complete treatment plan to include counseling and psychosocial support.

• Active ingredient or product type: BUPRENORPHINE HYDROCHLORIDE
• Strength/concentration: 2MG
• Dosage form and route: Tablet, Sublingual
• Exact package presentation: bottle of 30 tablets
• NDC/item number: 62756-459-83
• Manufacturer: SUN PHARMACEUTICAL
• Storage/handling: Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature]. Protect from light. Store buprenorphine sublingual tablets securely and dispose of properly [see Patient Counseling Information (17)] .
• Status: Rx only

Important safety information: Addiction, Abuse, and Misuse: Buprenorphine can be abused in a similar manner to other opioids.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.